TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 305 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2023. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,249,467 | +9.3% | 1,244,309 | +11.0% | 0.51% | +9.7% |
| Q2 2023 | $17,604,370 | -5.4% | 1,120,584 | -0.8% | 0.46% | +3.8% |
| Q1 2023 | $18,611,952 | -10.3% | 1,129,366 | -15.1% | 0.45% | -25.9% |
| Q4 2022 | $20,748,648 | +11.8% | 1,330,042 | -7.0% | 0.60% | +15.8% |
| Q3 2022 | $18,556,000 | -12.3% | 1,430,705 | -5.1% | 0.52% | -1.5% |
| Q2 2022 | $21,156,000 | -7.7% | 1,506,823 | -5.9% | 0.53% | -3.6% |
| Q1 2022 | $22,927,000 | +11.5% | 1,601,046 | +6.1% | 0.55% | +21.2% |
| Q4 2021 | $20,570,000 | -34.1% | 1,509,149 | -20.9% | 0.45% | -35.7% |
| Q3 2021 | $31,237,000 | -8.6% | 1,906,998 | -6.1% | 0.70% | +0.7% |
| Q2 2021 | $34,186,000 | +11.9% | 2,031,264 | +21.4% | 0.70% | +16.1% |
| Q1 2021 | $30,557,000 | +8.7% | 1,673,455 | +8.4% | 0.60% | +13.8% |
| Q4 2020 | $28,104,000 | +6.5% | 1,544,171 | +4.4% | 0.53% | +7.5% |
| Q3 2020 | $26,377,000 | -4.5% | 1,478,524 | -4.0% | 0.49% | -1.2% |
| Q2 2020 | $27,619,000 | -16.3% | 1,540,379 | -29.1% | 0.50% | -5.7% |
| Q1 2020 | $32,992,000 | -33.2% | 2,173,365 | -13.1% | 0.53% | -0.6% |
| Q4 2019 | $49,370,000 | +13.5% | 2,502,296 | -1.0% | 0.53% | +2.1% |
| Q3 2019 | $43,490,000 | -3.6% | 2,528,500 | -0.8% | 0.52% | +5.1% |
| Q2 2019 | $45,095,000 | -7.3% | 2,547,740 | +6.7% | 0.49% | +0.6% |
| Q1 2019 | $48,651,000 | +31.2% | 2,388,353 | +8.3% | 0.49% | +11.1% |
| Q4 2018 | $37,078,000 | – | 2,204,384 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |